WNT5A and Familial prostate cancer: miR-26a suppresses WNT-5A and forced expression of miR-26a attenuates cell proliferation, metastasis, and EMT, and induced G1 phase arrest suppressing WNT-5A expression and inhibiting prostate cancer progression [176].